Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy

With the increasing use of carbapenems, carbapenem-resistant Gram-negative bacteria have become a major concern in health care-associated infections. The present study was performed to evaluate the clinical and microbiological features of breakthrough Gram-negative bacteremia (GNB) during carbapenem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Lee, Ji-Yong, Kang, Cheol-In, Ko, Jae-Hoon, Lee, Woo Joo, Seok, Hye-Ri, Park, Ga Eun, Cho, Sun Young, Ha, Young Eun, Chung, Doo Ryeon, Lee, Nam Yong, Peck, Kyong Ran, Song, Jae-Hoon
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2016
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5075072/
https://ncbi.nlm.nih.gov/pubmed/27572416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00984-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars